TissueGene Awarded $750000 Maryland Stem Cell Grant for Invossa™ Clinical Study – PR Newswire (press release)
|
TissueGene Awarded $750000 Maryland Stem Cell Grant for Invossa™ Clinical Study
PR Newswire (press release) ROCKVILLE, Md., June 30, 2017 /PRNewswire/ — TissueGene, Inc. ("TissueGene"), a Maryland-based regenerative medicine company, announced today that the Maryland Stem Cell Research Fund (MSCRF) has awarded TissueGene a clinical grant for … |
